SQI Diagnostics Inc. announced that its Rapid Acute Lung Injury Diagnostic (RALI-Dx(TM)) IL-6 Severity Triage Test has been installed in two University Health Network (UHN) hospitals in Toronto to use as a clinical aid to help assess respiratory patients in the Emergency Department(ED) and as part of a study to help fight the growing respiratory health crisis in EDs.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -100.00% | -100.00% |
2023 | SQI Diagnostics Announces Resignation of Wilmot L. Matthews as Director | CI |
2023 | Clive J. Beddoe Announces Resignation as Director of SQI Diagnostics Inc | CI |
1st Jan change | Capi. | |
---|---|---|
-100.00% | 4.49M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- SQD.H Stock
- News SQI Diagnostics Inc.
- SQI Installs Two Rali-Dx Systems in Toronto Hospitals to Fight the Growing Respiratory Health Crisis in Emergency Departments